Corticosteroids and ocular mycoses: experimental study.
D000287:Administration, Topical; D000818:Animals; D001230:Aspergillus / Q000472:pathogenicity; D001232:Aspergillus fumigatus / Q000187:drug effects; D002467:Cell Nucleus; D003315:Cornea / Q000382:microbiology / Q000473:pathology; D003886:Descemet Membrane / Q000473:pathology; D004848:Epithelium / Q000187:drug effects / Q000473:pathology; D005128:Eye Diseases / Q000382:microbiology*; D005670:Fusarium / Q000472:pathogenicity; D005938:Glucocorticoids / Q000009:adverse effects*; D006854:Hydrocortisone / Q000008:administration & dosage / Q000009:adverse effects; D007267:Injections; D007275:Injections, Intravenous; D008775:Methylprednisolone / Q000009:adverse effects; D003904:Mitosporic Fungi / Q000472:pathogenicity; D009181:Mycoses / Q000473:pathology*; D009824:Ointments / Q000009:adverse effects; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D011817:Rabbits
D005938:Glucocorticoids; D009824:Ointments; D011239:Prednisolone; D006854:Hydrocortisone; D008775:Methylprednisolone